Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study

European Journal of Cancer

Volumn 51, Issue 15, 2015, Pages 2206-2216

  Trama, Annalisa ^a   Foschi, Roberto ^a   Larrañaga, Nerea ^b   Sant, Milena ^a   Fuentes Raspall, Rafael ^c   Serraino, Diego ^d   Tavilla, Andrea ^e   Eycken, Liesbet Van ^f   Nicolai, Nicola ^a   Hackl, M ^g   Zielonke, N ^g   Oberaigner, W ^h   Eycken, E Van ⁱ   Henau, K ⁱ   Valerianova, Z ^j   Dimitrova, N ^j   Sekerija, M ^k   Zvolsky M ^l   Dusek L ^l   Storm, H ^m   Engholm, G ^m   Magi M ⁿ   Aareleid, T ^o   Malila, N ^p   Seppa K ^p   Velten, M ^q   Troussard, X ^r   Bouvier, V ^s   Launoy, G ^s   Guizard, A V ^t   Faivre, J ^u   Bouvier, A M ^u   Arveux, P ^v   Maynadie M ^w   Woronoff, A S ^x   Robaszkiewicz, M ^y   Baldi, I ^z   Monnereau, A ^aa   Tretarre, B ^ab   Bossard, N ^ac   Belot, A ^ac   Colonna, M ^ad   Molinie F ^ae   Bara, S ^af   Schvartz, C ^ag   Lapotre Ledoux B ^ah   Grosclaude, P ^ai   Meyer, M ^aj   Stabenow, R ^ak   Luttmann, S ^al   Eberle, A ^al   Brenner, H ^am   Nennecke, A ^an   Engel, J ^ao   Schubert Fritschle, G ^ao   Kieschke, J ^ap   Heidrich, J ^aq   Holleczek, B ^ar   Katalinic, A ^as   Jonasson J G ^at   Tryggvadottir L ^at   Comber, H ^au   Mazzoleni, G ^av   Bulatko, A ^av   Buzzoni, C ^aw   Giacomin, A ^as   Sardo, A Sutera ^as   Mazzei, A ^as   Ferretti, S ^as   Crocetti, E ^as   Manneschi, G ^as   Gatta, G ^a   Amash, H ^a   Amati, C ^a   Baili, P ^a   Berrino, F ^a   Bonfarnuzzo, S ^a   Botta, L ^a   Salvo, F Di ^a   Margutti, C ^a   Meneghini, E ^a   Minicozzi, P ^a   Zucchetto, A ^ax   Angelis, R De ^e   Caldora, M ^e   Capocaccia, R ^e   Carrani, E ^e   Francisci, S ^e   Mallone, S ^e   Pierannunzio, D ^e   Roazzi, P ^e   Rossi, S ^e   Santaquilani, M ^e   Pannozzo, F ^as   Busco, S ^as   Bonelli, L ^ay   Vercelli, M ^ay   Gennaro, V ^az   Ricci, P ^as   Autelitano, M ^as   Randi, G ^as   Ponz De Leon, M ^ba   Marchesi, C ^as   Cirilli, C ^as   Fusco, M ^bb   Vitale, M F ^bb   Usala, M ^as   Traina, A ^bc   Zarcone, M ^bc   Vitale, F ^as   Cusimano, R ^as   Michiara, M ^as   Tumino, R ^as   Rossi, P Giorgi ^as   Vicentini, M ^as   Falcini, F ^bd   Iannelli, A ^as   Sechi, O ^as   Cesaraccio, R ^as   Piffer, S ^be   Madeddu, A ^as   Tisano, F ^as   Maspero, S ^as   Fanetti, A C ^as   Zanetti, R ^as   Rosso, S ^as   Candela, P ^as   Scuderi, T ^as   Stracci, F ^bf   Rocca, A ^bf   Tagliabue, G ^a   Contiero, P ^a   Tos, A P Dei ^bg   Tognazzo, S ^bg   Pildava, S ^bh   Smailyte, G ^bi   Calleja, N ^bj   Micallef, R ^bj   Johannesen, T B ^bk   Rachtan, J ^bl   Gozdz S ^bm   Gozdz R ^bm   Me zyk, J ^bn   Kepska, K ^bn   Bielska Lasota, M ^bo   Forjaz de Lacerda, G ^bp   Bento, M J ^bq   Antunes, L ^bq   Miranda, A ^br   Mayer Da silva, A ^br   Nicula, F ^bs   Coza, D ^bs   Diba, C Safaei ^bt   Primic Zakelj, M ^bu   Almar, E ^bv   Mateos, A ^bv   Errezola, M ^bw   Torrella Ramos, A ^bx   García, J M Díaz ^by   Marcos Navarro, A I ^by   Marcos Gragera, R ^bz   Vilardell, L ^bz   Sanchez, M J ^b   Molina, E ^b   Navarro, C ^ca   Chirlaque, M D ^ca   Moreno Iribas, C ^b   Ardanaz, E ^b   Galceran, J ^cb   Carulla, M ^cb   Lambe, M ^cc   Khan, S ^cd   Mousavi, M ^ce   Bouchardy, C ^cf   Usel, M ^cf   Ess, S M ^cg,ci   Frick, H ^cg   Lorez, M ^ch   Herrmann, C ^ci   Bordoni, A ^cj   Spitale, A ^cj   Konzelmann, I ^ck   Visser, O ^cl   Aben, K ^cl   Coleman, M ^cm   Allemani, C ^cm   Rachet, B ^cm   Verne, J ^cn   Easey, N ^cn   Lawrence, G ^cn   Moran, T ^cn   Rashbass, J ^cn   Roche, M ^cn   Wilkinson, J ^cn   Gavin, A ^co   Fitzpatrick, D ^co   Brewster, D H ^cp   Huws, D W ^cq   White, C ^cq   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f Belgian Cancer Registry   (Belgium)

^g Austrian CR   (Austria)

^h Tyrol CR   (Austria)

ⁱ Belgian CR   (Belgium)

^j Bulgarian CR   (Bulgaria)

^k Croatian CR   (Croatia)

^l Czech National CR   (Czech Republic)

^m DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁿ Estonian CR   (Estonia)

^o NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^p Finnish CR   (Finland)

^q Bas Rhin CR   (France)

^r Basse Normandie Haematological malignancies CR   (France)

^s Calvados Digestive Tract Registry   (France)

^t General CR   (France)

^u Burgundy   (France)

^v Côte d Or Gynaecologic CR   (France)

^w Côte d Or Haematological Malignancies CR   (France)

^x Doubs CR   (France)

^y Finistère Digestive Tract Registry   (France)

^z Gironde CNS CR   (France)

^aa Gironde Haematological Malignancies CR   (France)

^ab Hérault CR   (France)

^ac HOSPICES CIVILS DE LYON   (France)

^ad Isère CR   (France)

^ae Loire Atlantique CR   (France)

^af Manche CR   (France)

^ag Thyroid CR   (France)

^ah Somme CR   (France)

^ai Tarn CR   (France)

^aj Bavaria CR   (Germany)

^ak Brandenburg CR   (Germany)

^al LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^am GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^an Hamburg CR   (Germany)

^ao Munich CR   (Germany)

^ap Niedersachsen CR   (Germany)

^aq North Rhine Westphalia CR   (Germany)

^ar Saarland CR   (Germany)

^as Saarland CR ^*  (Italy)

^at Icelandic CR   (Iceland)

^au NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^av Alto Adige CR   (Italy)

^aw Associazione Italiana Registri Tumore   (Italy)

^ax CRO Aviano National Cancer Institute   (Italy)

^ay IRCCS AOU SM IST   (Italy)

^az Liguria Mesothelioma CR   (Italy)

^ba Modena colorettali CR   (Italy)

^bb Napoli 3 South CR   (Italy)

^bc Palermo Breast CR   (Italy)

^bd IRCCS AUSLIRST Meldola   (Italy)

^be Azienda Provinciale per i Servizi Sanitari   (Italy)

^bf Umbria CR   (Italy)

^bg Veneto CR   (Italy)

^bh Latvian CR   (Latvia)

^bi Lithuanian CR   (Lithuania)

^bj Malta National Cancer Registry   (Malta)

^bk Norwegian CR   (Norway)

^bl Cracow CR   (Poland)

^bm Kielce CR   (Poland)

^bn University of Lower Silesia   (Poland)

^bo NATIONAL MEDICINES INSTITUTE   (Poland)

^bp Açores CR   (Portugal)

^bq Northern Portugal CR   (Portugal)

^br Southern Portugal CR   (Portugal)

^bs THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^bt Slovakian National CR   (Slovakia)

^bu INSTITUTE OF ONCOLOGY   (Slovenia)

^bv Albacete Castilla La Mancha CR   (Spain)

^bw Basque Country CR   (Spain)

^bx breast   (Spain)

^by Cuenca CR   (Spain)

^bz Girona CR   (Spain)

^ca IMIB Arrixaca   (Spain)

^cb Tarragona CR   (Spain)

^cc KAROLINSKA INSTITUTE   (Sweden)

^cd Swedish CR   (Sweden)

^ce Zoo Basel   (Switzerland)

^cf Geneva CR   (Switzerland)

^cg Grisons Glarus CR   (Switzerland)

^ch NICER   (Switzerland)

^ci St Gallen CR   (Switzerland)

^cj Ticino CR   (Switzerland)

^ck Valais CR   (Switzerland)

^cl The Netherlands CR   (Netherlands)

^cm LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^cn PUBLIC HEALTH ENGLAND   (United Kingdom)

^co Northern Ireland CR   (United Kingdom)

^cp Scottish CR   (United Kingdom)

^cq Welsh Cancer Intelligence Surveillance Unit   (United Kingdom)

more..

Author keywords

Cancer registries; Penile cancers; Prostate; Survival; Survival trends; Testicular

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CONFIDENCE INTERVAL; EASTERN EUROPE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NORTHERN EUROPEAN; PENIS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SOUTHERN EUROPE; SURVIVAL TIME; TESTIS CANCER; UNITED KINGDOM;

EID: 84942474474     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.07.027     Document Type: Article

References (47)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: < http://globocan.iarc.fr > [accessed 17.02.15].
2. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber, and et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 2013 1374 1403
3. M. Arnold, H.E. Karim-Kos, J.M. Coebergh, G. Byrnes, A. Antilla, J. Ferlay, and et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory Eur J Cancer 51 9 2015 1164 1187
4. C. Bosetti, P. Bertuccio, M. Malvezzi, F. Levi, Negri E. Chatenoud, and et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980 Ann Oncol 24 10 2013 2657 2671
5. O. Visser, J. Adolfsson, S. Rossi, J. Verne, G. Gatta, M. Maffezzini, and et al. Incidence and survival of rare urogenital cancers in Europe Eur J Cancer 48 4 2012 456 464
6. A. Znaor, J. Lortet-Tieulent, M. Laversanne, A. Jemal, and F. Bray International testicular cancer incidence trends: generational transitions in 38 countries 1900-1990 Cancer Causes Control 26 1 2015 151 158
7. Rossi S, Baili P, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, et al. The EUROCARE-5 study on cancer survival in Europe 1999-2007: database, quality checks and statistical analysis method. Eur J Cancer 2015;51:2104-19.
8. C. Percy, A. Fritz, A. Jack, S. Shanmugarathan, L. Sobin, D.M. Parkin, and et al. International classification of diseases for the oncology (ICD-O) 3rd ed. 2000 World Health Organisation Geneva
9. H. Brenner, B. Soderman, and T. Hakulinen Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland Int J Epidemiol 31 2002 456 462
10. I. Corazziari, M. Quinn, and R. Capocaccia Standard cancer patients population for age standardizing survival ratios Eur J Cancer 40 2004 2307 2316
11. T.W. Anderson An introduction to multivariate statistical analysis 2nd ed. 1984 John Wiley & Sons New York
12. A. Gondos, A. Krilaviciute, G. Smailyte, A. Ulys, and H. Brenner Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme Eur J Cancer 51 2015 1630 1637
13. L.M. Burt, D.C. Shrieve, and J.D. Tward Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis Int J Radiat Oncol Biol Phys 88 1 2014 94 100
14. N.M. Graafland, R.H.A. Verhoeven, J.W.W. Coebergh, and S. Horenblas Incidence trends and survival of penile squamous cell carcinoma in the Netherlands Int J Cancer 128 2011 426 432
15. I.Y. Dechev, A.V. Banchev, and N.G. Mateva Epidemiology, diagnostic and therapeutic problems for carcinoma of the penis in the regions of Plovdiv, Pazardzhik and Smolyan between 1993 and 2002 Folia Med 47 3-4 2005 33 39
16. J. Novák, J. Bárta, and P. Klézl Carcinoma of the penis Cas Lek Cesk 146 10 2007 767 770
17. R.H.A. Verhoeven, M.L.G. Janssen-Heijnen, K.U. Saum, R. Zanetti, A. Caldarella, B. Holleczek, and et al. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990 Eur J Cancer 49 2013 1414 1421
18. M. Arya, R. Li, K. Pegler, V. Sangar, J.D. Kelly, S. Minhas, and et al. Long-term trends in incidence, survival and mortality of primary penile cancer in England Cancer Causes Control 24 2013 2169 2176
19. F. Bray, A. Klint, M. Gislum, T. Hakulinen, G. Engholm, L. Tryggvadóttir, and et al. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006 Acta Oncol 49 5 2010 644 654
20. C. Protzel, and O.W. Hekenberg Penile cancer - a challenge for modern uro-oncology Aktuelle Urol 44 5 2013 363 369
21. L.C. Pagliaro, D.L. Williams, D. Daliani, M.B. Williams, W. Osai, M. Kincaid, and et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study J Clin Oncol 28 24 2010 3851 3857
22. R.S. Djajadiningrat, N.M. Graafland, E. van Werkhoven, W. Meinhardt, A. Bex, H.G. van der Poel, and et al. Contemporary management of regional nodes in penile cancer improvement of survival? J Urol 191 1 2014 68 73
23. R.S. Djajadiningrat, A.M. Bergman, E. van Werkhoven, E. Vegt, and S. Horenblas Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer Clin Genitourin Cancer 2014 [Epub ahead of print]
24. S. Nicholson, E. Hall, S.J. Harland, J.D. Chester, L. Pickering, J. Barber, and et al. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001) Br J Cancer 109 2013 2554 2559
25. National Institute for Health and Clinical Excellence, editor. Improving Outcomes in Urological Cancer. London: NICE; 2002.
26. A. Bayles, and K.K. Sethia The impact of improving outcomes guidance on the management and outcomes of patients with carcinoma of the penis Ann R Coll Surg Engl 92 2010 44 45
27. A. Trama, S. Mallone, N. Nicolai, A. Necchi, M. Schaapveld, J. Gietema, and et al. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe Eur J Cancer 48 2 2012 159 169
28. R.H. Verhoeven, A. Gondos, M.L. Janssen-Heijnen, K.U. Saum, D.H. Brewster, B. Holleczek, and et al. Testicular cancer in Europe and the USA: survival still rising among older patients Ann Oncol 24 2013 508 513
29. F. Bray, L. Richiardi, A. Ekboom, E. Pukkala, M. Cuninkova, and H. Møller Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality Int J Cancer 118 2006 3099 3111
30. C. Bosetti, P. Bertuccio, L. Chatenoud, E. Negri, C. La Vecchia, and F. Levi Trends in mortality from urologic cancers in Europe, 1970-2008 Eur Urol 60 1 2011 1 15
31. T. Aareleid, A. Gondos, H. Brenner, H. Pokker, K. Leppik, and M. Mägi Testicular cancer survival in Estonia: improving but still relatively low Acta Oncol 50 1 2011 99 105
32. A. Juška, A. Ulys, L. Kairevičė, G. Smailytė, E. Stankevičius, R. Jančiauskienė, and et al. Survival of patients with testicular cancer in Lithuania during 1999-2002 Medicina (Kaunas) 47 1 2011 52 56
33. N. Sincic, T. Kulis, A. Znaor, and F. Bray Time trends in testicular cancer in Croatia 1983-2007: rapid increases in incidence, no declines in mortality Cancer Epidemiol 36 1 2012 11 15
34. A. Krilaviciute, G. Smailyte, H. Brenner, and A. Gondos Cancer survival in Lithuania after the restoration of independence: rapid improvements, but persisting major gaps Acta Oncol 53 9 2014 1238 1244
35. R.H. Verhoeven, H.E. Karim-Kos, J.W. Coebergh, M. Brink, S. Horenblas, R. de Wit, and et al. Markedly increased incidence and improved survival of testicular cancer in the Netherlands Acta Oncol 53 3 2014 342 350
36. C.G. Ruf, H. Isbarn, W. Wagner, M. Fisch, C. Matthies, and K.P. Dieckmann Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing Urol Oncol 32 2014 33.e1 33.e6
37. A. Stang, C. Rusner, and R. Stabenow Changing epidemiologic features of testicular germ cell cancer in Germany: corroboration at population level Urol Oncol 31 2013 1839 1840
38. A.W. van den Belt-Dusebout, R. de Wit, J.A. Gietema, S. Horenblas, M.W. Louwman, J.G. Ribot, and et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 25 28 2007 4370 4378
39. M.S. Thong, F. Mols, K.D. Stein, T. Smith, J.W. Coebergh, and L.V. van de Poll-Franse Population-based cancer registries for quality-of-life research: a work-in-progress resource for survivorship studies? Cancer 119 11 2013 2109 2123
40. F. Bray, J. Lortet-Tieulent, J. Ferlay, D. Forman, and A. Auvinen Prostate cancer incidence and mortality trends in 37 European countries: an overview Eur J Cancer 46 2010 3040 3052
41. R.G. Cremers, H.E. Karim-Kos, S. Houterman, R.H. Verhoeven, F.H. Schröder, T.H. van der Kwast, and et al. Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006 Eur J Cancer 46 11 2010 2077 2087
42. R. De Angelis, M. Sant, M.P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study Lancet Oncol 15 2014 23 34
43. M. Arnold, H.E. Karim-Kos, J.W. Coebergh, G. Byrnes, A. Antilla, J. Ferlay, and et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory Eur J Cancer 51 2015 1164 1187
44. T. Xiong, R.M. Turner, Y. Wei, D.E. Neal, G. Lyratzopoulos, and J.P. Higgins Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis BMJ Open 4 5 2014 e004285 10.1136/bmjopen-2013-004285
45. N. Fossati, Q.-D.C. Trinh, J. Sammon, A. Sood, A. Larcher, M. Sun, and et al. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: A SEER-based study Eur Urol 67 1 2015 3 6
46. H. Huland, and M. Graefen Changing trends in surgical management of prostate cancer: the end of overtreatment? Eur Urol 2015 10.1016/j.eururo.2015.02.020 pii: S0302-2838(15)00182-7. [Epub ahead of print] See comment in PubMed Commons below
47. F.H. Schröder, J. Hugosson, M.J. Roobol, T.L. Tammela, M. Zappa, V. Nelen, and et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up Lancet 384 9959 2014 2027 2035